According to German Business Daily, French pharmaceutical company Sanofi is about to decide to invest 1.3 billion to 1.5 billion euros (about 1.4 billion to 1.6 billion US dollars) in a large production base in Frankfurt, Germany, to produce insulin Lantus. The report cited German government sources as saying that Sanofi changed its route after initially considering moving Lantus production to France, and the company is now close to committing to upgrading its German factory in the Hürth district of Frankfurt.
赛诺菲计划在德国投资至多16亿美元升级工厂
Sanofi plans to invest up to $1.6 billion to upgrade its factory in Germany.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.